Celularity announced that its board of directors has approved a 1-for-10 reverse stock split of its Class A common stock, to be effective at 5:00 p.m. Eastern Standard Time, Wednesday, February 28. Celularity’s Class A common stock is expected to begin trading on a split-adjusted basis on the Nasdaq Capital Market on Thursday, February 29, under the current trading symbol.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CELU:
- Celularity Executives Face Salary Cuts and New Incentives
- Celularity Issues Business Update for Investor Awareness
- Celularity sees FY24 net sales of biomaterial product, biobanking $50M-$56M
- Celularity sees Q1 net sales of biomaterial product, biobanking $10.25M-$11.5M
- Celularity comments on closing $21M financing transactions
